{"id":47842,"date":"2012-06-20T11:22:47","date_gmt":"2012-06-20T11:22:47","guid":{"rendered":"http:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/uncategorized\/penn-study-describes-molecular-machinery-that-pulls-apart-protein-clumps.php"},"modified":"2012-06-20T11:22:47","modified_gmt":"2012-06-20T11:22:47","slug":"penn-study-describes-molecular-machinery-that-pulls-apart-protein-clumps","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/molecular-medicine\/penn-study-describes-molecular-machinery-that-pulls-apart-protein-clumps.php","title":{"rendered":"Penn Study Describes Molecular Machinery that Pulls Apart Protein Clumps"},"content":{"rendered":"<p><p>    PHILADELPHIA  Amyloid fibers are protein aggregates associated    with numerous neurodegenerative diseases, including Parkinson's    disease, for which there are no effective treatments.  <\/p>\n<p>    However, on the flip side, the fibers can also play beneficial,    protective roles. In yeast, they are associated with increased    survival and the evolution of new traits. In humans, they form    biological nanostructures to house pigments and other molecules    and may also be central to long-term memory formation and    storage. Amyloid fibers are among the most stable protein-based    structures in nature, and so when they are detrimental, as in    Parkinson's disease, they are notoriously difficult for cells    to break down.  <\/p>\n<p>    In a new study published in PLoS Biology this week,    James    Shorter, PhD, assistant professor of Biochemistry    and Biophysics, Perelman School of Medicine    at the University of Pennsylvania, and colleagues    address an urgent need to find ways to promote beneficial    amyloid fiber assembly or to reverse its pathogenic assembly,    at will.  <\/p>\n<p>    In the paper, Shorter and colleagues define the mechanisms by    which small heat-shock proteins (hsp) collaborate with other    molecular chaperones to regulate the assembly and disassembly    of a beneficial yeast prion (an amyloid that can spread between    individuals).  <\/p>\n<p>    Yeast harbor a declumping protein called Hsp104, which rapidly    disassembles amyloid fibers, and this activity is greatly    enhanced by small heat shock proteins. Humans and other    animals, however, lack Hsp104, and so the puzzle has always    been: Can human cells also disassemble these exceptionally    stable amyloid fibers?  <\/p>\n<p>    In this study, Shorter and colleagues establish that in the    absence of Hsp104, the yeast small heat shock proteins    collaborate with other molecular chaperones to slowly    depolymerize the amyloid fibers by removing one fiber subunit    at a time from the tips of the fibers. This activity was    extremely surprising as traditionally the small heat shock    proteins and other molecular chaperones are famous for their    duties in preventing protein clumping. They were not previously    known to reverse the assembly of exceptionally stable amyloid    fibers that were already formed.  <\/p>\n<p>    Importantly, the proteins of the amyloid-depolymerase machinery    is conserved to humans. Thus, even without Hsp104, human small    heat shock proteins can collaborate with human molecular    chaperones to slowly depolymerize amyloid fibers. For example,    it is now clear that human cells harbor the necessary machinery    to clear amyloid fibers connected with neurodegenerative    disease.  <\/p>\n<p>    \"Remarkably, the human small heat shock protein, HspB5,    stimulates other heat shock proteins, Hsp110, Hsp70, and Hsp40,    to gradually depolymerize amyloid fibers formed by    alpha-synuclein, which are implicated in Parkinson's disease,    from their ends on a biologically relevant timescale. Because    monomers [shorter segments] are released by this system and not    toxic oligomers [longer segments], we believe this is an    extremely safe way to dissolve amyloid\" explains Shorter.  <\/p>\n<p>    This newly identified and highly conserved amyloid-depolymerase    system could have important therapeutic applications for    various neurodegenerative disorders, suggest the researchers.    The goal is to stimulate the machinery in humans to pull apart    the fibers where and when needed by increasing the expression    of heat shock proteins to hopefully pull apart already-formed    amyloid fibers. The next step will be to boost the activity of    the newly discovered amyloid-depolymerase system, perhaps with    drug-like small molecules, in animal models of    neurodegenerative disease.  <\/p>\n<p>    The research is supported by the American Federation for Aging    Research; the William Wood Foundation; the Hereditary Disease    Foundation; an NIH Director's New Innovator Award    (1DP2OD002177-01); an Ellison Medical Foundation New Scholar in    Aging Award; a National Institute of Neurological Disorders and    Stroke grant (1R21NS067354-0110); a Bill & Melinda Gates    Foundation Grand Challenges Explorations Award; and a    University of Pennsylvania Diabetes and Endocrinology Research    Center Pilot and Feasibility grant.  <\/p>\n<\/p>\n<p>Read the original here: <\/p>\n<p><a target=\"_blank\" href=\"http:\/\/www.uphs.upenn.edu\/news\/News_Releases\/2012\/06\/clumps\/\" title=\"Penn Study Describes Molecular Machinery that Pulls Apart Protein Clumps\">Penn Study Describes Molecular Machinery that Pulls Apart Protein Clumps<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p> PHILADELPHIA Amyloid fibers are protein aggregates associated with numerous neurodegenerative diseases, including Parkinson's disease, for which there are no effective treatments. However, on the flip side, the fibers can also play beneficial, protective roles. In yeast, they are associated with increased survival and the evolution of new traits.  <a href=\"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/molecular-medicine\/penn-study-describes-molecular-machinery-that-pulls-apart-protein-clumps.php\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"limit_modified_date":"","last_modified_date":"","_lmt_disableupdate":"","_lmt_disable":"","footnotes":""},"categories":[26],"tags":[],"class_list":["post-47842","post","type-post","status-publish","format-standard","hentry","category-molecular-medicine"],"modified_by":null,"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/47842"}],"collection":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/comments?post=47842"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/47842\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/media?parent=47842"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/categories?post=47842"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/tags?post=47842"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}